The Claim
The overdiagnosis rate for lung cancer detected by low-dose computed tomography (LDCT) screening decreases substantially with longer follow-up periods, indicating that the excess cancer detection observed in short-term trials is primarily attributable to lead time bias rather than true overdiagnosis.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When doctors scan lungs with a special X-ray to find cancer early, they sometimes find cancers that would never have caused harm. But if they watch people for a longer time, fewer of these harmless cancers show up—suggesting that the early scans just found cancers sooner, not that they found more dangerous ones.
See the scientific wording
The overdiagnosis rate for lung cancer detected by LDCT screening decreases substantially with longer follow-up, suggesting that much of the excess cancer detection observed in short-term trials is due to lead time rather than true overdiagnosis.
Score breakdown, mechanism chain, raw evidence, ideal studies needed
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.